An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color

• Published in: Journal of drugs in dermatology Vol. 23; no. 6; p. 410
• Main Authors: El-Kashlan, Nour, Cices, Ahuva, Kaufman, Bridget, Da Rosa, Joel Correa, Sanabria-Gonzalez, Ingrid, Khattri, Saakshi, Alexis, Andrew
• Format: Journal Article
• Language: English
• Published: United States 01.06.2024
• Subjects: Acne Vulgaris - drug therapy; Administration, Cutaneous; Adolescent; Adult; Dapsone - administration & dosage; Dapsone - adverse effects; Female; Gels; Humans; Hyperpigmentation - chemically induced; Hyperpigmentation - drug therapy; Male; Quality of Life; Severity of Illness Index; Skin Pigmentation - drug effects; Treatment Outcome; Young Adult

Acne vulgaris is a common skin disease prevalent in skin of color patients. Studies have demonstrated that dapsone gel, 7.5% (Aczone) used once daily is effective, safe, and well-tolerated for the treatment of acne in both men and women. However, minimal data are available in skin of color populatio...